Fumeaux Coralie, Bernhardt Thomas G
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, USA.
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, USA
mBio. 2017 Mar 28;8(2):e00102-17. doi: 10.1128/mBio.00102-17.
Peptidoglycan (PG) is an essential cross-linked polymer that surrounds most bacterial cells to prevent osmotic rupture of the cytoplasmic membrane. Its synthesis relies on penicillin-binding proteins, the targets of beta-lactam antibiotics. Many Gram-negative bacteria, including the opportunistic pathogen , are resistant to beta-lactams because of a chromosomally encoded beta-lactamase called AmpC. In , expression of the gene is tightly regulated and its induction is linked to cell wall stress. We reasoned that a reporter gene fusion to the promoter would allow us to identify mutants defective in maintaining cell wall homeostasis and thereby uncover new factors involved in the process. A library of transposon-mutagenized was therefore screened for mutants with elevated promoter activity. As an indication that the screen was working as expected, mutants with transposons disrupting the gene were isolated. Defects in DacB have previously been implicated in induction and clinical resistance to beta-lactam antibiotics. The screen also uncovered and mutants that, upon further characterization, displayed nearly identical drug resistance and sensitivity profiles. We present genetic evidence that , renamed , encodes the missing phosphatase predicted to function in the MurU PG recycling pathway that is widely distributed among Gram-negative bacteria. The cell wall biogenesis pathway is the target of many of our best antibiotics, including penicillin and related beta-lactam drugs. Resistance to these therapies is on the rise, particularly among Gram-negative species like , a problematic opportunistic pathogen. To better understand how these organisms resist cell wall-targeting antibiotics, we screened for mutants defective in maintaining cell wall homeostasis. The screen identified a new factor, called MupP, involved in the recycling of cell wall turnover products. Characterization of MupP and other components of the pathway revealed that cell wall recycling plays important roles in both the resistance and the sensitivity of to cell wall-targeting antibiotics.
肽聚糖(PG)是一种必需的交联聚合物,它围绕着大多数细菌细胞,以防止细胞质膜发生渗透性破裂。其合成依赖于青霉素结合蛋白,而青霉素结合蛋白是β-内酰胺类抗生素的作用靶点。许多革兰氏阴性菌,包括机会致病菌,由于一种名为AmpC的染色体编码β-内酰胺酶而对β-内酰胺类药物耐药。在该菌中, 基因的表达受到严格调控,其诱导与细胞壁应激相关。我们推测,与 启动子融合的报告基因将使我们能够鉴定出在维持细胞壁稳态方面存在缺陷的突变体,从而发现该过程中涉及的新因子。因此,我们筛选了一个转座子诱变的 文库,以寻找 启动子活性升高的突变体。作为筛选按预期进行的一个指标,我们分离出了转座子破坏 基因的突变体。此前已发现DacB缺陷与 诱导及对β-内酰胺类抗生素的临床耐药性有关。该筛选还发现了 突变体和 突变体,进一步表征后发现它们具有几乎相同的耐药性和敏感性谱。我们提供了遗传学证据,证明重命名为 的 编码一种缺失的磷酸酶,预计该磷酸酶在广泛存在于革兰氏阴性菌中的MurU PG回收途径中发挥作用。细胞壁生物合成途径是我们许多最佳抗生素(包括青霉素和相关β-内酰胺类药物)的作用靶点。对这些疗法的耐药性正在上升,尤其是在像 这样有问题的机会致病菌等革兰氏阴性菌中。为了更好地了解这些生物体如何抵抗针对细胞壁的抗生素,我们筛选了在维持细胞壁稳态方面存在缺陷的 突变体。该筛选鉴定出了一个参与细胞壁周转产物回收的新因子,称为MupP。对MupP和该途径其他成分的表征表明,细胞壁回收在 对针对细胞壁的抗生素的耐药性和敏感性中都起着重要作用。